NEVVI Medicare utilization intelligence
or

← back

Provider profile

WOLFE, DAVID MD

Rheumatology · NPI 1104825249 · CHEVY CHASE, MD

2
Groups
60
Codes · 2024
105,089
Disclosed services

WOLFE, DAVID is a Rheumatology in CHEVY CHASE, MD, a member of 2 medical groups, who billed 60 distinct codes to Medicare Part B in 2024.

Groups: ARTHRITIS AND RHEUMATISM ASSOCIATES PC (ROCKVILLE, MD) · SUBURBAN/NRH MEDICAL REHABILITATION INC (BETHESDA, MD) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

105,089
disclosed services
60
codes billed to Medicare Part B
Prior year · CY2023 101,288 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3262 Injection, tocilizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J3111 Injection, romosozumab-aqqg, 1 mg
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1602 Injection, golimumab, 1 mg, for intravenous use
J1745 Injection, infliximab, excludes biosimilar, 10 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
36415 Insertion of needle into vein for collection of blood sample
J1010 Injection, methylprednisolone acetate, 1 mg
80053 Blood test, comprehensive group of blood chemicals
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
86140 Measurement c-reactive protein for detection of infection or inflammation
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
85652 Red blood cell sedimentation rate, to detect inflammation, automated
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
86235 Measurement of antibody for assessment of autoimmune disorder, any method
77080 Dxa bone density measurement of hip, pelvis, spine
82306 Vitamin d-3 level
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
73130 X-ray of hand, minimum of 3 views
20610 Aspiration and/or injection of fluid from large joint
73110 X-ray of wrist, minimum of 3 views
97530 Therapy procedure using functional activities
86160 Measurement of complement (immune system proteins), antigen,
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
97110 Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes
84165 Protein measurement, serum
84550 Uric acid level, blood
73630 X-ray of foot, minimum of 3 views
82310 Calcium level, total
86431 Rheumatoid factor level
96415 Administration of chemotherapy into vein, each additional hour
86255 Screening test for antibody to noninfectious agent
97112 Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes
86200 Measurement of antibody for rheumatoid arthritis assessment
73562 X-ray of knee, 3 views
86038 Screening test for autoimmune disorder
97140 Therapy procedure using manual technique, each 15 minutes
82570 Creatinine level to test for kidney function or muscle injury
73030 X-ray of shoulder, minimum of 2 views
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
84155 Total protein level, blood
81001 Manual urinalysis test with examination using microscope, automated
72100 X-ray of lower and sacral spine, 2-3 views
84156 Total protein level, urine
97164 Re-evaluation for physical therapy, typically 20 minutes
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
82550 Creatine kinase (cardiac enzyme) level, total
20605 Aspiration and/or injection of fluid from medium joint
82340 Urine calcium level
80061 Blood test, lipids (cholesterol and triglycerides)
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
84443 Blood test, thyroid stimulating hormone (tsh)
72040 X-ray of upper spine, 2-3 views
72170 X-ray of pelvis, 1-2 views

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.